Top 10 Companies in the Strontium‑88 Market (2026): Market Leaders Driving Global Isotope Innovation

MARKET INSIGHTS

Global Strontium‑88 market size was valued at USD 89 million in 2025. The market is projected to grow from USD 94 million in 2026 to USD 118.5 million by 2034, exhibiting a CAGR of 5.0% during the forecast period. The influence of COVID‑19 and geopolitical factors such as the Russia‑Ukraine conflict were considered in market sizing.

Strontium‑88 is a stable isotope with applications spanning isotope production, geological research, and nuclear medicine. As one of the four naturally occurring isotopes of strontium, it plays a crucial role in radiopharmaceutical applications due to its non‑radioactive properties and use as a precursor for medical isotopes. The 99.0%‑99.5% purity segment currently dominates market demand, particularly for precision applications.

While North America leads current market consumption, Asia‑Pacific is projected to witness the fastest growth through 2034, driven by expanding nuclear medicine infrastructure in China and India. Recent supply chain disruptions have highlighted the strategic importance of stable isotope production, with major players like Rosatom and CNNC expanding production capacities. However, stringent regulatory requirements for isotope applications continue to present market entry barriers for new participants.

Strontium‑88 Market – View in Detailed Research Report

Top 10 Companies in the Strontium‑88 Market

10️⃣ Rosatom

Headquarters: Moscow, Russia
Key Offering: High‑purity Strontium‑88 production, isotope enrichment services

Rosatom, Russia’s state nuclear corporation, remains the global leader in Strontium‑88 supply, leveraging its extensive isotope production infrastructure and government‑backed research initiatives. With over 28% of 2025 global supply, Rosatom supplies high‑purity material to medical, geological, and research sectors.

Sustainability & Growth Initiatives:

• Expansion of isotope production facilities across Russia and Eastern Europe
• Investment in advanced laser‑based separation technology
• Partnerships with national laboratories to develop next‑generation radioisotopes

9️⃣ Isoflex

Headquarters: Denver, Colorado, USA
Key Offering: Rare‑earth purification, Strontium‑88 supply for medical isotope production

Isoflex has carved a niche in the U.S. market with its diversified rare‑earth portfolio and specialized purification capabilities. The company has captured nearly 10% of the U.S. Strontium‑88 market share through targeted contracts with medical isotope manufacturers.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient electromagnetic separation units
• Collaboration with academic institutions for isotope research
• Expansion of domestic production to reduce import reliance

8️⃣ American Elements

Headquarters: San Diego, California, USA
Key Offering: Strontium‑88 supply, isotope enrichment, custom purification

American Elements has positioned itself as a leading U.S. supplier, providing high‑purity Strontium‑88 to the nuclear medicine and research communities. The company’s focus on quality and regulatory compliance has driven its growth.

Sustainability & Growth Initiatives:

• Investment in automated quality control systems
• Partnerships with federal research agencies for isotope development
• Expansion of production capacity in the Midwest

7️⃣ Trace Sciences International

Headquarters: Toronto, Canada
Key Offering: Strontium‑88 distribution, isotope analysis services

Trace Sciences International has strengthened its distribution network across Europe and Asia through targeted acquisitions. The company offers comprehensive isotope analysis services, supporting geological and environmental research.

Sustainability & Growth Initiatives:

• Expansion of European distribution hubs
• Investment in mass‑spectrometry upgrades
• Collaboration with mining companies for isotope mapping

6️⃣ CNNC (China National Nuclear Corporation)

Headquarters: Beijing, China
Key Offering: Large‑scale Strontium‑88 production, isotope enrichment

CNNC has emerged as a significant competitor through strategic capacity expansions, supplying both domestic and international markets. Its investments in nuclear research facilities have positioned CNNC as a key player in the Asia‑Pacific region.

Sustainability & Growth Initiatives:

• Construction of new isotope production plants in Guangdong
• Collaboration with Chinese universities for isotope research
• Development of high‑purity production lines

5️⃣ NIDC (Nuclear Industry Development Corporation)

Headquarters: Tokyo, Japan
Key Offering: Strontium‑88 supply, nuclear research support

NIDC supports Japan’s nuclear research programs by providing high‑purity Strontium‑88 for experimental and medical applications. The company focuses on maintaining stringent quality standards.

Sustainability & Growth Initiatives:

• Investment in energy‑efficient separation technologies
• Partnerships with Japanese research institutes
• Expansion of domestic production to meet local demand

4️⃣ BATAN (National Institute of Nuclear Energy)

Headquarters: Jakarta, Indonesia
Key Offering: Strontium‑88 supply, isotope research services

BATAN supplies Strontium‑88 for Indonesia’s growing research and medical isotope programs. The institute focuses on developing local production capabilities to reduce dependency on imports.

Sustainability & Growth Initiatives:

• Construction of a new isotope production facility
• Collaboration with Indonesian universities for isotope research
• Implementation of renewable energy sources for production

3️⃣ Radium Nuclear Technologies

Headquarters: Houston, Texas, USA
Key Offering: Strontium‑88 production, custom isotope solutions

Radium Nuclear Technologies specializes in custom isotope solutions for medical and industrial applications. The company has secured contracts with several leading pharmaceutical manufacturers.

Sustainability & Growth Initiatives:

• Adoption of green chemistry practices in isotope production
• Investment in high‑efficiency laser separation
• Expansion of U.S. production capacity

2️⃣ SinoStrontium

Headquarters: Shanghai, China
Key Offering: Strontium‑88 supply, isotope enrichment services

SinoStrontium has positioned itself as a key supplier in the Asia‑Pacific market, focusing on high‑purity production for medical isotope manufacturers.

Sustainability & Growth Initiatives:

• Development of energy‑efficient production lines
• Partnerships with Chinese research institutions
• Expansion of domestic distribution network

1️⃣ U.S. Nuclear Materials Inc.

Headquarters: Albuquerque, New Mexico, USA
Key Offering: Strontium‑88 supply, isotope processing services

U.S. Nuclear Materials Inc. supplies Strontium‑88 to both domestic and international markets, focusing on stringent regulatory compliance and high‑quality standards.

Sustainability & Growth Initiatives:

• Implementation of waste‑reduction protocols in isotope processing
• Collaboration with U.S. federal agencies for isotope research
• Expansion of production facilities in the Southwest

Download FREE Sample Report

Get Full Report Here

Market Outlook

The Strontium‑88 market is poised for steady expansion, driven by the growing demand for medical isotopes, expanding geological research, and the need for precise isotope monitoring in nuclear energy programs. Regulatory tightening and supply chain vulnerabilities may temper growth, but technological advancements in isotope separation and high‑purity production are expected to unlock new revenue streams.

Future Trends

• Accelerated adoption of laser‑based isotope separation reducing production costs by up to 50%
• Expansion of Strontium‑89 and Strontium‑90 therapeutic applications for bone cancer and neurodegenerative diseases
• Growth of betavoltaic battery markets utilizing Strontium‑90 decay for remote power applications
• Increased focus on regulatory harmonization to streamline cross‑border isotope trade
• Emergence of new market players in the Asia‑Pacific region driven by domestic nuclear research initiatives